Takeda Pharmaceutical Company

Research Takeda Pharmaceutical Company (TAK) on Bullrun: market cap USD 50.49B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTAK
• ExchangeNYSE
• CountryJapan
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 50.49B
• Financial periodQ1 2026
• RevenueUSD 4.51T
• Net incomeUSD 191.76B
• Free cash flowUSD 626.77B
• Gross margin65.1%

Valuation Snapshot

latest market cap is USD 50.49B.

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Frequently asked questions

What is Takeda Pharmaceutical Company's market cap?

Takeda Pharmaceutical Company's market capitalization is USD 50.49B.

What does Takeda Pharmaceutical Company do?

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.